Antihypertensive Effectiveness of Low-Dose Lisinopril-Hydrochlorothiazide Combination: A Large Multicenter Study

Archives of Internal Medicine

Volumn 154, Issue 7, 1994, Pages 737-743

  Chrysant, Steven G ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LISINOPRIL; POTASSIUM;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; DRUG POTENCY; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; PHARYNGITIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; VERTIGO;

BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HEART RATE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0028296024     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1994.00420070047005     Document Type: Article

References (40)

1. Chrysant SG. Experience with terazosin administered in combination with other antihypertensive agents. Am J Med. 1986;80(suppl 5B):55-61.
2. Chrysant SG, Chrysant C, Bal IS, Trus J, Hitchcock A. Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens: hemodynamic aspects. Chest. 1989;96:499-504.
3. Chrysant SG, Chrysant C, Trus J, Hitchcock A. Antihypertensive effectiveness of amlodipine in combination with hydrochlorothiazide. Am J Hypertens. 1989; 2:537-541.
4. Chrysant SG, Chappel C, Farnham DJ, et al. Antihypertensive and metabolic effects of single and combined atenolol regimens. J Clin Pharmacol. 1992;32: 61-65.
5. Holland OB, Kuhnert L, Campbell WB, Anderson RJ. Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. Hypertension. 1983;5:235-239.
6. Chrysant SG, Bal IS, Johnson B, McPherson M. A comparative study of captopril and enalapril in patients with severe hypertension. J Clin Pharmacol. 1985; 25:149-151.
7. Kochar M, Bolek G, Kalbfleisch J, Olzinski P. A 52-week comparison of lisinopril, hydrochlorothiazide, and their combination in hypertension. J Clin Pharmacol. 1987;27:373-377.
8. Pool J, Gennari J, Goldstein R, et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1987;9(suppl 3):36-42.
9. Mehta J, Lopez L, Thorman A. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. Am J Cardiol. 1988;61:803-806.
10. Weinberger MH. Angiotensin converting enzyme inhibitors enhance the antihypertensive efficacy of diuretics and blunt or prevent adverse metabolic effects. J Cardiovasc Pharmacol. 1989;13(suppl 3):1-4.
11. DeQuattro V. Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide. Clin Cardiol. 1991; 14(suppl 4):28-32.
12. Chrysant SG, Neller GK, Dillard BL, Frohlich ED. Effects of diuretics on lipid metabolism in patients with essential hypertension. Angiology. 1976;27:707-711.
13. Weinberger MH. The influence of an angiotensin converting enzyme inhibitor, captopril, on diuretic-induced metabolic effects in hypertension. Hypertension. 1983;5(suppl 3):132-138.
14. Weinberger MH. Diuretics and their side effects: dilemma in the treatment of hypertension. Hypertension. 1988;11(suppl 2):16-20.
15. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med. 1990;150:1175-1183.
16. Ruoff G. ACE inhibitors and diuretics. Postgrad Med. 1989;3:127-139.
17. Grimm RH Jr, Leon AF, Hunninghake DB. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med. 1981; 94:7-11.
18. Gomez HJ, Cirillo VJ, Sromousky JA, et al. Lisinopril dose-response relationship in essential hypertension. Br J Clin Pharmacol. 1989;28:415-420.
19. Chrysant SG, Chrysant C, Trus J, Watson-Hitchcock A. Antihypertensive effectiveness of lisinopril and metoprolol alone and in combination with other drugs. Curr Ther Res. 1989;45:238-244.
20. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med. 1993; 153:154-183.
21. Moser M. Diuretics in the management of hypertension. Med Clin North Am. 1987;71:935-946.
22. Gavras H. A multicenter trial of enalapril in the treatment of essential hypertension. Clin Pharmacol Ther. 1985;88:199-204.
23. Davies RO, Irvin JD, Dramach DK, Walker JF, Moncloa F. Enalapril: worldwide experience. Am J Med. 1984;77(suppl 2A):28-35.
24. Heel RC, Brogden RN, Speight TM, Avery GS. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs. 1980;20: 409-452.
25. Veterans Administration Study Group on Antihypertensive Agents: Low-dose captopril for the treatment of mild to moderate hypertension. Hypertension. 1983;5(suppl 3):139-144.
26. Kayanakis JG, Baulac L. Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension. Br J Clin Pharmacol. 1987;23:89S-92S.
27. Vidt DG. A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension. J Hypertens. 1984;2(suppl 2):81-88.
28. Biollaz J, Burnier M, Turini OA, et al. Three new long-acting converting enzyme inhibitors: relationship between plasma converting enzyme activity and response to angiotensin I. Clin Pharmacol Ther. 1981;29:665-670.
29. Berglund G, Anderson O. Low doses of hydrochlorothiazide in hypertension: antihypertensive and metabolic effects. Eur J Clin Pharmacol. 1976;10:177-182.
30. Freis ED. Critique of the clinical importance of diuretic induced hypokalemia and elevated cholesterol level. Arch Intern Med. 1989;149:2640-2648.
31. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349-1354.
32. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
33. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
34. MRC Working Party. Medical Research Council trial of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
35. Waeber B, Gavras I, Brunner HR, Gavras H. Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update. J Cardiovasc Pharmacol. 1981;21:508-516.
36. Chrysant SG, Danisa K, Kem DL, Smith WJ, Dillard BL, Frohlich ED. Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension. 1979;1:136-141.
37. Weinberger MH. Blood pressure and metabolic response to hydrochlorothiazide, captopril and the combination in black and white mild to moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7:S52-S55.
38. Jenkins AC, Knill JR, Dreslinski GR. Captopril in the treatment of the elderly hypertensive patient. Arch Intern Med. 1985;145:2029-2031.
39. Bidiville J, Nussberger J, Waeber G, Porchet M, Waeber B, Brunner HR. Individual responses to converting enzyme inhibitors and calcium antagonists. Hypertension. 1988;11:166-173.
40. Fitzgerald JD. The influence of the medication on compliance with therapeutic regimens. In: Sackett DR, Haynes RB, eds. Compliance With Therapeutic Regimens. Baltimore, Md: Johns Hopkins University Press; 1976:119-128.